Compounds > dexelvucitabine
Page last updated: 2024-08-24

dexelvucitabine and Hepatitis B

dexelvucitabine has been researched along with Hepatitis B in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitra, AK; Patel, J1

Reviews

1 review(s) available for dexelvucitabine and Hepatitis B

ArticleYear
ACH-126443 Achillion/Yale University.
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:11

    Topics: Animals; Clinical Trials as Topic; Hepatitis B; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Technology, Pharmaceutical; Zalcitabine

2002

Other Studies

1 other study(ies) available for dexelvucitabine and Hepatitis B

ArticleYear
ViroLogic announces agreement with Achillion.
    Pharmacogenomics, 2002, Volume: 3, Issue:2

    Topics: Clinical Trials, Phase II as Topic; Cooperative Behavior; Drug Industry; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; Humans; Zalcitabine

2002